-The aim of this study was to determine the effect of ethanol (EtOH) on endothelial monocyte chemotactic protein-1 (MCP-1) expression. IL-1 increased the production of MCP-1 by human umbilical vein endothelial cells from undetectable levels to ϳ900 pg/ml at 24 h. EtOH dose-dependently inhibited IL-1-stimulated MCP-1 secretion as determined by ELISA: 25 Ϯ 1%, 35 Ϯ 7%, and 65 Ϯ 5% inhibition for 1, 10, and 100 mM EtOH, respectively, concomitant with inhibition of monocyte adhesion to activated endothelial cells. Similarly, EtOH dose-dependently inhibited IL-1-stimulated MCP-1 mRNA expression. Experiments with actinomycin D demonstrated that EtOH decreased the stability of MCP-1 mRNA. In addition, EtOH significantly reduced NF-B and AP-1 binding activity induced by IL-1 and inhibited MCP-1 gene transcription. Binding of 125 I-labeled MCP-1 to its receptor (CCR2) on THP-1 human monocytic cells was not affected by EtOH treatment. Modulation of the expression of MCP-1 represents a mechanism whereby EtOH could inhibit atherogenesis by blocking the crucial early step of monocyte adhesion and subsequent recruitment to the subendothelial space. These actions of EtOH may underlie, in part, its cardiovascular protective effects in vivo.alcohol; chemokines; atherogenesis CARDIOVASCULAR DISEASE REMAINS the leading cause of death in the Western world. Although chronic alcohol abuse is associated with increased morbidity and mortality, epidemiologic studies associate moderate alcohol consumption with a reduced incidence of cardiovascular disease (14,18,32). Most of the benefit of alcohol appears to be conferred by a reduction in atherosclerotic risk (12,36). However, the precise cellular mechanisms whereby ethanol (EtOH) elicits its cardioprotective effects are not yet fully understood. In addition to favorable effects on plasma lipoprotein levels, potentially beneficial effects of EtOH on platelets and on vascular endothelial cells and smooth muscle cells (SMC) have been recently reported (6,10,11,24,26).Monocyte chemotactic protein-1 (MCP-1) is a member of the C-C chemokine family and a potent chemoattractant for monocytes (27). The involvement of MCP-1 in the pathogenesis of atherosclerosis has been widely investigated, and much evidence exists to support its central role in the process.Migration of monocytes across the endothelial barrier is a significant early event in the formation of atherosclerotic lesions. Several studies provide compelling evidence for a direct role of MCP-1 in monocyte recruitment during atherosclerosis. In response to several atherogenic stimulants such as oxidized LDL, PDGF, and IL-1, MCP-1 is induced in endothelial cells, SMC, and monocytes (31, 33). The expression of MCP-1 and other chemokines is thought to be regulated primarily at the level of gene transcription, although contributions by posttranslational mechanisms have also been reported (35). The promoter region of the MCP-1 gene contains binding sites for the redox-responsive transcription factors NF-B and AP-1 (16). MCP-1 mediates it...